dear owl&fox thanks you for sharing your observations.
I have located a presentation on the dimx website , a poster from 2018 describing phase2 fgs trial design which also contains graphic of proteinuria results from the basket ckd phase 2 trial you described, in 27 people done by each person, split by diabetes, iga n and "others".
---it isn't clear if anybody with fsg was included under the "others". if there weren't any fsg but they at least had some useful signal in iganeph then it is odd to me they went off after fsg and did not prioritise Igan in the follow up phase 2.
---so to me if there current fsg action3 trial when it reads out final results some time second half of this decade is positive then good for them BUT
---- going after fsg instead of iganeph history could say was a strategic blunder. they might have sewn up an even bigger global deal earlier.
all imo.
- Forums
- ASX - By Stock
- DXB
- DXB Media thread.
DXB Media thread., page-70
-
- There are more pages in this discussion • 216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.5¢ |
Change
0.020(5.48%) |
Mkt cap ! $214.4M |
Open | High | Low | Value | Volume |
37.0¢ | 39.0¢ | 36.5¢ | $688.5K | 1.801M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13148 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 279673 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 323631 | 0.385 |
4 | 43184 | 0.380 |
6 | 79618 | 0.375 |
12 | 259509 | 0.370 |
15 | 1205714 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 249673 | 9 |
0.395 | 186347 | 7 |
0.400 | 645840 | 11 |
0.405 | 12408 | 2 |
0.410 | 79546 | 5 |
Last trade - 15.32pm 02/10/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |